SPATCCM

SPATCCM
[[File:|250px|]]
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Seizures, Headaches, Focal neurological deficits
Complications	Intracerebral hemorrhage
Onset
Duration
Types	N/A
Causes	Genetic mutation
Risks
Diagnosis	MRI, Genetic testing
Differential diagnosis	N/A
Prevention	N/A
Treatment	Surgical resection, Symptomatic management
Medication	N/A
Prognosis
Frequency
Deaths	N/A

SPATCCM (Specific Polymorphism Associated with the Cerebral Cavernous Malformation) is a genetic condition characterized by the presence of cerebral cavernous malformations (CCMs) in the brain. These are clusters of abnormal blood vessels that can lead to various neurological symptoms and complications.

Pathophysiology

Cerebral cavernous malformations are vascular lesions that consist of clusters of dilated blood vessels. These lesions can occur anywhere in the central nervous system but are most commonly found in the brain. The walls of these vessels are thin and prone to leakage, which can result in intracerebral hemorrhage.

The condition is often associated with mutations in one of three genes: KRIT1, CCM2, or PDCD10. These genes are involved in the maintenance of vascular integrity and endothelial cell function. Mutations lead to the disruption of normal blood vessel formation and maintenance, resulting in the development of CCMs.

Clinical Presentation

Patients with SPATCCM may present with a variety of symptoms depending on the location and size of the malformations. Common symptoms include:

• Seizures
• Headaches
• Focal neurological deficits such as weakness or numbness
• Vision problems

In some cases, patients may remain asymptomatic, and the condition is discovered incidentally during imaging for other reasons.

Diagnosis

The diagnosis of SPATCCM is typically made through magnetic resonance imaging (MRI), which can reveal the characteristic appearance of cavernous malformations. Genetic testing can confirm the diagnosis by identifying mutations in the associated genes.

Management

Management of SPATCCM involves both symptomatic treatment and surgical intervention.

• Symptomatic management: This includes the use of antiepileptic drugs for seizure control and pain management for headaches.
• Surgical resection: In cases where lesions are accessible and symptomatic, surgical removal of the malformation may be considered to prevent further complications.

Prognosis

The prognosis for individuals with SPATCCM varies depending on the number and location of the malformations, as well as the presence of symptoms. Regular monitoring and management of symptoms can help improve quality of life.

Also see

• Cerebral cavernous malformation
• Genetic disorders
• Neurology
• Vascular malformations

edit 

WikiMD neurology

External links

• Comprehensive information from the National Institute of health.
  

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z